{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:00:21Z","timestamp":1761919221639,"version":"3.37.0"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2222,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1002\/hep.22831","type":"journal-article","created":{"date-parts":[[2009,3,23]],"date-time":"2009-03-23T19:57:04Z","timestamp":1237838224000},"page":"652","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Treatment with immunosuppressives in patients with primary biliary cirrhosis who fail to respond to ursodiol\u2020"],"prefix":"10.1097","volume":"50","author":[{"given":"Marshall M.","family":"Kaplan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raoul","family":"Poupon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"-20241201","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/hep.22428","article-title":"Biochemical response to ursodeoxycholic acid and long\u2010term prognosis in prieary biliary cirrhosis","volume":"48","author":"Corpechot","year":"2008","journal-title":"HEPATOLOGY"},{"key":"-20241201","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/0016-5085(91)90085-Y","article-title":"Treatment of primary biliary cirrhosis with low\u2010dose weekly methotrexate","volume":"101","author":"Kaplan","year":"1991","journal-title":"Gastroenterology"},{"key":"-20241201","doi-asserted-by":"crossref","first-page":"682","DOI":"10.7326\/0003-4819-126-9-199705010-00002","article-title":"Sustained biochemical and histologic remission of primary biliary cirrhosis in response to medical treatment","volume":"126","author":"Kaplan","year":"1997","journal-title":"Ann Intern Med"},{"key":"-20241201","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1053\/gast.1999.0029900395","article-title":"Methotrexate in primary biliary cirrhosis unresponsive to ursodeoxycholic acid: An observational study in ten patients","volume":"117","author":"Bonis","year":"1999","journal-title":"Gastroenterology"},{"key":"-20241201","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1572-0241.2003.07182.x","article-title":"Efficacy of colchicine in patients with primary biliary cirrhosis poorly responsive to ursodiol and methotrexate","volume":"98","author":"Lee","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"-20241201","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0168-8278(96)80327-8","article-title":"Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis","volume":"25","author":"Leuschner","year":"1996","journal-title":"J Hepatol"},{"key":"-20241201","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S0016-5085(99)70351-3","article-title":"Oral budesonide and ursodeoxycholic acid for treatment of primary biliary cirrhosis: results of a prospective double\u2010blind trial","volume":"117","author":"Leuschner","year":"1999","journal-title":"Gastroenterology"},{"key":"-20241201","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/hep.20646","article-title":"Budesonide combined with UDCA to improve liver histology in primary biliary cirrhosis: a three\u2010year randomized trial","volume":"41","author":"Rautiainen","year":"2005","journal-title":"HEPATOLOGY"},{"key":"-20241201","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/hep.20103","article-title":"A randomized controlled trial of colchicine plus ursodiol versus methotrexate plus ursodiol in primary biliary cirrhosis: ten\u2010year results","volume":"39","author":"Kaplan","year":"2004","journal-title":"HEPATOLOGY"},{"key":"-20241201","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1056\/NEJM198612043152304","article-title":"A prospective trial of colchicine in primary biliary cirrhosis","volume":"315","author":"Kaplan","year":"1986","journal-title":"N Engl J Med"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.22831","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200908000-00043","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T16:57:06Z","timestamp":1739033826000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200908000-00043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.22831","relation":{},"ISSN":["0270-9139"],"issn-type":[{"type":"print","value":"0270-9139"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}